Skip to main content
. 2019 Jul 17;42(10):1028–1040. doi: 10.1002/clc.23232

Table 2.

Recommended risk scoring systems for the assessment of ischemic and bleeding risk in patients with NSTEMI15, 68, 69, 70

GRACE TIMI CRUSADE
Risk measured Ischemic Ischemic Bleeding
Risk estimated
  • Mortality while in hospital, at 6 months, at 1 year, and at 3 years

  • The combined risk of death or MI at 1 year

  • Adverse outcome (death, MI, urgent revascularization)

  • In‐hospital major bleeding event

Variables used to calculate score Age, systolic blood pressure, pulse rate, serum creatinine, Killip class at presentation, cardiac arrest at admission, elevated cardiac biomarkers, and ST deviation Age ≥65 years, ≥3 CAD risk factors, known CAD, aspirin use in the past 7 days, severe angina (≥2 episodes within 24 hours), ST change ≥0.5 mm, and positive cardiac marker Baseline hematocrit, diabetes mellitus, GFR: Cockcroft‐Gault, heart rate on admission, prior vascular disease, sex, signs of CHF on admission, and systolic blood pressure on admission
Online calculator https://www.mdcalc.com/grace‐acs‐risk‐mortality‐calculator https://www.mdcalc.com/timi‐risk‐score‐ua‐nstemi http://www.crusadebleedingscore.org/

Abbreviations: CAD, coronary artery disease; CHF, congestive heart failure; CRUSADE, Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines; GFR, glomerular filtration rate; GRACE, Global Registry of Acute Coronary Events; MI, myocardial infarction; NSTEMI, non‐ST‐segment elevation myocardial infarction; TIMI, Thrombolysis In Myocardial Infarction.